QA: Kinnate Biopharma Inc in us_pharma/2023

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001797768_2024_Kinnate_Biopharma_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001797768, Kinnate Biopharma Inc

  xvar xval
0 AssetsCurrent 158,177,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 2,272,000
3 remainder_Assets 13,156,000
4 LiabilitiesCurrent 11,995,000
5 LiabilitiesNoncurrent 2,283,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 28,241,000
9 ResearchAndDevelopmentExpense 90,767,000
10 remainder_Expenses 2,168,000
11 remainder_Revenues 0
12 remainder_NetIncome 8,527,000
13 remainder_ComprehensiveNetIncome 1,398,000
  yvar yval
0 Assets 173,605,000
1 Liabilities 14,278,000
2 Expenses 121,176,000
3 Revenues 0
4 StockholdersEquity 159,327,000
5 NetIncome -112,649,000
6 ComprehensiveNetIncome -111,950,000
7 BaseVar 159,492,000
8 EconomicCapitalRatiobeforeLimitedLiability 2.51
9 EconomicCapitalRatio 3.36

Edgar->Model Mapping

Feature Distribution

Change over Time